DSGN
Price
$13.35
Change
-$0.09 (-0.67%)
Updated
Jun 26 closing price
Capitalization
833.8M
42 days until earnings call
Intraday BUY SELL Signals
SYRE
Price
$87.89
Change
-$0.78 (-0.88%)
Updated
Jun 26 closing price
Capitalization
7.63B
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs SYRE

DSGN vs SYRE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DSGN vs. SYRE commentary
Jun 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a StrongBuy and SYRE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2026
Stock price -- (DSGN: $13.35 vs. SYRE: $87.89)
Brand notoriety: DSGN and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 284% vs. SYRE: 329%
Market capitalization -- DSGN: $833.8M vs. SYRE: $7.63B
DSGN [@Biotechnology] is valued at $833.8M. SYRE’s [@Biotechnology] market capitalization is $7.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, both DSGN and SYRE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 5 bearish.
  • SYRE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both DSGN and SYRE are a good buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а +7.32% price change this week, while SYRE (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

Reported Earning Dates

DSGN is expected to report earnings on Aug 10, 2026.

SYRE is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($7.63B) has a higher market cap than DSGN($834M). SYRE YTD gains are higher at: 168.285 vs. DSGN (42.324). DSGN has higher annual earnings (EBITDA): -78.14M vs. SYRE (-241.64M). SYRE has more cash in the bank: 741M vs. DSGN (223M). SYRE has less debt than DSGN: SYRE (0) vs DSGN (2.73M). DSGN (0) and SYRE (0) have equivalent revenues.
DSGNSYREDSGN / SYRE
Capitalization834M7.63B11%
EBITDA-78.14M-241.64M32%
Gain YTD42.324168.28525%
P/E RatioN/A1.72-
Revenue00-
Total Cash223M741M30%
Total Debt2.73M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNSYRE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 8 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
SYRE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIOS13.461.74
+14.85%
AIOS Tech Inc.
NCNO15.631.28
+8.92%
nCino
MANH137.859.98
+7.80%
Manhattan Associates
WENNU10.41N/A
N/A
Wen Acqusition Corp
ENHA2.84-0.04
-1.39%
Enhanced Group Inc.